Evidence based approach to practice guides and decision thresholds for cardiac markers
- 1 January 1999
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 59 (sup230) , 90-102
- https://doi.org/10.1080/00365519909168332
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Value of Troponins in Predicting Therapeutic Efficacy of Abciximab in Patients With Unstable AnginaJournal of the American College of Cardiology, 1998
- Early Diagnostic Efficiency of Cardiac Troponin I and Troponin T for Acute Myocardial InfarctionAcademic Emergency Medicine, 1997
- Mathematical tools for demonstrating the clinical usefulness of biochemical markersScandinavian Journal of Clinical and Laboratory Investigation, 1997
- An Evaluation of Technologies for Identifying Acute Cardiac Ischemia in the Emergency Department: A Report from a National Heart Attack Alert Program Working GroupAnnals of Emergency Medicine, 1997
- Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1996
- Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial IschemiaNew England Journal of Medicine, 1996
- Value of Myoglobin, Troponin T, and CK-MB mass in Ruling Out an Acute Myocardial Infarction in the Emergency RoomCirculation, 1995
- The prognostic significance of immunoradiometric CK-MB assay (IRMA) diagnosis of myocardial infarction in patients with low total CK and elevated MB isoenzymesAmerican Heart Journal, 1989
- The Creatine Kinase System in Normal and Diseased Human MyocardiumNew England Journal of Medicine, 1985
- Symptomatic myocardial infarction without chest pain: Prevalence and clinical courseThe American Journal of Cardiology, 1977